379 related articles for article (PubMed ID: 28053340)
1. Population screening and treatment of Helicobacter pylori infection.
O'Connor A; O'Morain CA; Ford AC
Nat Rev Gastroenterol Hepatol; 2017 Apr; 14(4):230-240. PubMed ID: 28053340
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation.
Roderick P; Davies R; Raftery J; Crabbe D; Pearce R; Patel P; Bhandari P
J Med Screen; 2003; 10(3):148-56. PubMed ID: 14561268
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
5. Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Hansen JM; Wildner-Christensen M; Hallas J; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2008 May; 103(5):1106-13. PubMed ID: 18445098
[TBL] [Abstract][Full Text] [Related]
6. Cost-benefit analysis of testing for Helicobacter pylori in dyspeptic subjects.
Sonnenberg A
Am J Gastroenterol; 1996 Sep; 91(9):1773-7. PubMed ID: 8792696
[TBL] [Abstract][Full Text] [Related]
7. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
8. [Anti-ulcer therapy after eradication of Helicobacter pylori].
Imoto I; Taguchi Y
Nihon Rinsho; 2001 Feb; 59(2):328-32. PubMed ID: 11218407
[TBL] [Abstract][Full Text] [Related]
9. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer.
Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA
Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560
[TBL] [Abstract][Full Text] [Related]
10. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K; Okada H; Shiratori Y
Am J Gastroenterol; 2005 May; 100(5):1037-42. PubMed ID: 15842576
[TBL] [Abstract][Full Text] [Related]
11. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.
Chiba N; Lahaie R; Fedorak RN; Bailey R; Veldhuyzen van Zanten SJ; Bernucci B
Can Fam Physician; 1998 Jul; 44():1481-8. PubMed ID: 9678277
[TBL] [Abstract][Full Text] [Related]
13. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
14. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease.
Jang EJ; Park SW; Park JS; Park SJ; Hahm KB; Paik SY; Sin MK; Lee ES; Oh SW; Park CY; Baik HW
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S278-85. PubMed ID: 19120912
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
[TBL] [Abstract][Full Text] [Related]
16. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Rosengren H; Polson RJ
Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention.
Lansdorp-Vogelaar I; Sharp L
Best Pract Res Clin Gastroenterol; 2013 Dec; 27(6):933-47. PubMed ID: 24182612
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori and peptic ulcer disease.
Ateshkadi A; Lam NP; Johnson CA
Clin Pharm; 1993 Jan; 12(1):34-48. PubMed ID: 8428432
[TBL] [Abstract][Full Text] [Related]
19. [The drug treatment of gastric and duodenal peptic ulcer].
Grigor'ev PIa
Ter Arkh; 1995; 67(4):73-8. PubMed ID: 7784986
[No Abstract] [Full Text] [Related]
20. Helicobacter pylori public health implications.
Moayyedi P; Hunt RH
Helicobacter; 2004; 9 Suppl 1():67-72. PubMed ID: 15347308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
